These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6857991)

  • 21. Tobacco mosaic virus coat protein: an elicitor of the hypersensitive reaction but not required for the development of mosaic symptoms in Nicotiana sylvestris.
    Culver JN; Dawson WO
    Virology; 1989 Dec; 173(2):755-8. PubMed ID: 2596036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
    Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
    Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous application of double-stranded RNA molecules from TMV p126 and CP genes confers resistance against TMV in tobacco.
    Konakalla NC; Kaldis A; Berbati M; Masarapu H; Voloudakis AE
    Planta; 2016 Oct; 244(4):961-9. PubMed ID: 27456838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of amino acid replacement on the stability of the tobacco mosaic virus protein structure.
    Ruttkay-Nedecký G; Veselá V
    Acta Virol; 1977 Sep; 21(5):365-74. PubMed ID: 22230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coat protein interactions involved in tobacco mosaic tobamovirus cross-protection.
    Lu B; Stubbs G; Culver JN
    Virology; 1998 Sep; 248(2):188-98. PubMed ID: 9721228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors.
    Shivprasad S; Pogue GP; Lewandowski DJ; Hidalgo J; Donson J; Grill LK; Dawson WO
    Virology; 1999 Mar; 255(2):312-23. PubMed ID: 10069957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TMV Particles: The Journey From Fundamental Studies to Bionanotechnology Applications.
    Lomonossoff GP; Wege C
    Adv Virus Res; 2018; 102():149-176. PubMed ID: 30266172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against tobacco mosaic virus infection in transgenic plants requires accumulation of coat protein rather than coat protein RNA sequences.
    Powell PA; Sanders PR; Tumer N; Fraley RT; Beachy RN
    Virology; 1990 Mar; 175(1):124-30. PubMed ID: 2309438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological properties and biological function of monoclonal antibodies to tobacco mosaic virus.
    Dietzgen RG
    Arch Virol; 1986; 87(1-2):73-86. PubMed ID: 3942505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proteinless mutant of tobacco mosaic virus: evidence against the role of a viral coat protein for interference.
    Sarkar S; Smitamana P
    Mol Gen Genet; 1981; 184(1):158-9. PubMed ID: 6950193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping nucleotides in the 126-kDa protein gene that control the differential symptoms induced by two strains of tobacco mosaic virus.
    Shintaku MH; Carter SA; Bao Y; Nelson RS
    Virology; 1996 Jul; 221(1):218-25. PubMed ID: 8661430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural studies on the coat protein of alfalfa mosaic virus. Isolation and characterization of the tryptic peptides and the alignment of the cyanogen-bromide fragments.
    Van Beynum GM; Kraal B; De Graaf JM; Bosch L
    Eur J Biochem; 1975 Mar; 52(2):231-8. PubMed ID: 1175586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro translation of the RNAs of four tobamoviruses.
    Beier H; Mundry KW; Issinger OG
    Intervirology; 1980; 14(5-6):292-9. PubMed ID: 7251334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete uncoating of the 5' leader sequence of tobacco mosaic virus RNA occurs rapidly and is required to initiate cotranslational virus disassembly in vitro.
    Mundry KW; Watkins PA; Ashfield T; Plaskitt KA; Eisele-Walter S; Wilson TM
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():769-77. PubMed ID: 1849966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coat-protein-mediated resistance to tobacco mosaic virus: discovery mechanisms and exploitation.
    Beachy RN
    Philos Trans R Soc Lond B Biol Sci; 1999 Mar; 354(1383):659-64. PubMed ID: 10212946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural studies on the coat protein of alfalfa mosaic virus. The complete primary structure.
    van Beynum GM; de Graaf JM; Castel A; Kraal B; Bosch L
    Eur J Biochem; 1977 Jan; 72(1):63-78. PubMed ID: 836394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementation of coat protein-defective TMV mutants in transgenic tobacco plants expressing TMV coat protein.
    Osbourn JK; Sarkar S; Wilson TM
    Virology; 1990 Dec; 179(2):921-5. PubMed ID: 2238482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of repeated sequences from tobacco mosaic virus mutants with two coat protein genes.
    Beck DL; Dawson WO
    Virology; 1990 Aug; 177(2):462-9. PubMed ID: 2371767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA-Directed Assembly of Tobacco Mosaic Virus (TMV)-Like Carriers with Tunable Fractions of Differently Addressable Coat Proteins.
    Eiben S
    Methods Mol Biol; 2018; 1776():35-50. PubMed ID: 29869233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amino acid sequence of the cowpea strain of tobacco mosaic virus protein.
    Rees MW; Short MN
    Biochim Biophys Acta; 1975 May; 393(1):15-23. PubMed ID: 1138919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.